Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001079973-25-000193
Filing Date
2025-02-07
Accepted
2025-02-07 16:34:16
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 cdio_s3.htm S-3 372298
2 OPINION OF SHARTSIS FRIESE LLP ex5x1.htm EX-5.1 21186
3 OPINION OF SHARTSIS FRIESE LLP (RELATING TO THE SALES AGREEMENT PROSPECTUS) ex5x2.htm EX-5.2 7511
4 CONSENT OF PRAGER METIS CPAS LLC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23x1.htm EX-23.1 1831
5 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 20997
6 GRAPHIC image_001.jpg GRAPHIC 3552
7 GRAPHIC image_002.jpg GRAPHIC 12597
  Complete submission text file 0001079973-25-000193.txt   447503
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

EIN.: 870925574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284775 | Film No.: 25602391
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)